The AIM-HI Accelerator Fund is honored to be nominated for the 2022 Prix Galien USA Incubators, Accelerators and Equity Award.

The newest Prix Galien Award category, “Incubators, Accelerators and Equity,” acknowledges the role played by organizations in guiding the next wave of innovators, by offering a range of mentoring skills including clinical trial design expertise, legal counsel, lab space, professional development, peer-to-peer support, free access to leading advisors and economic support to advance life science innovation.

At AIM-HI, we bridge the gap between innovative, early-stage cancer research and successful development of high-impact oncology products. Our integrated approach combines essential funding with development and business expertise, leading to successful oncology companies that bring forth new biomedical discoveries that create value and benefit society.

To be nominated alongside other esteemed nominees is a testament to the hard work and dedication of our staff, founders, advisory members, directors and volunteers. We are honored to be recognized by this prestigious nomination and look forward to continuing our mission of advancing innovative cancer research through collaboration and entrepreneurship.

We would like to thank all of our supporters who have helped us reach this point, including our sponsors and donors.

“That is my strength. I don’t give up easily; if I believe in certain things, I won’t give up no matter how hard it is.”

Profile Preview:

Sujuan Ba locked eyes with the job interviewer and knew, in that moment, she had a monumental decision to make. She could tell him what he wanted to hear, or she could tell him the truth.

Sitting across from Sujuan was Dr. Michael Griffin, the Vice President of Research and Development for ARCO Chemical Company, where she was attempting to land her first job after graduating with Ph.D. in Chemistry from the University of Pennsylvania. Dr. Griffin asked Sujuan where she wanted to be in five years, a question never before posed to her, and she knew immediately it was not in a laboratory conducting research as she had in school and theoretically would be in the role she was interviewing for. Using all the cliché buzzwords she knew, Sujuan hesitantly expressed to Dr. Griffin that her long-term interests actually lied more on the business side of science than in research.

“He was really surprised,” Sujuan recalls, “asking me, ‘Why do you think you can do that? You don’t have the business background.’ …

Read the full interview with AIM-HI CEO & Co-Founder Sujuan Ba, here.